This site contains the South Australian Clinical Prioritisation Criteria (CPC) for most frequently referred endocrinology conditions.
Endocrinology conditions
Please note this is not an exhaustive list of all conditions for outpatient services and does not exclude consideration for referral unless specifically stipulated in the endocrinology exclusions section.
- Adrenal Incidentaloma/Mass
- Adrenal Insufficiency
- Calcium and Bone Disorders
- Diabetes
- Diabetes
- Hypercalcaemia and Hyperparathyroidism
- Hypernatraemia and Hyponatraemia
- Hyperprolactinaemia
- Hyperthyroidism
- Hypocalcaemia
- Hypoglycaemia in Patients Without Known Diabetes Mellitus
- Hypothyroidism
- Male Hypogonadism
- Oligo/Amenorrhoea, Hirsutism, Acne, Female Infertility
- Osteoporosis and Metabolic Bone Disease
- Pituitary Adenoma
- Pituitary and Adrenal Disorders
- Polycystic Ovary Syndrome (PCOS) - Endocrinology
- Polycystic Ovary Syndrome (PCOS) and Obesity - Endocrinology
- Pubertal Disorders
- Short Stature
- Thyroid Disorders
- Thyroid Nodules
Out of scope
Not all medical conditions are covered by the CPC, as certain conditions may be considered out of scope or managed by other specialist services:
- diabetic foot ulceration – refer to High-Risk Foot — Vascular CPC
- renal bone disease – refer to nephrology
- suspected or confirmed thyroid nodule malignancy - refer to Breast and Endocrine
- transgender medicine – refer to the statewide service via fax (08) 8161 2591
- significant bowing of limbs and/or other nutritional deficiencies, refer to paediatric medicine
- abnormal liver function tests (LFTs) – refer to gastroenterology
- hypertension, refer to nephrology
- obstructive sleep apnoea (OSA), refer to respiratory and sleep medicine
- gender dysphoria/transgender, refer to Gender Identity — Paediatric Medicine CPC
Exclusions for public specialist outpatient services
Not all endocrinology conditions are appropriate for referral into the South Australian public health system. The following are not routinely provided in a public specialist outpatient service.
- age-appropriate osteopenia without fracture/s
- clinically stable hypothyroidism
- dietary advice for weight reduction, high cholesterol, hypertension or cardiovascular disease (CVD) for individuals with diabetes
- hypothyroidism without cardiac disease or pregnant women, and where thyroxine treatment is contraindicated without first-line management
- impaired glucose tolerance or impaired fasting glucose
- metabolic bone disease, when the person’s life expectancy is less than 6 months
- newly diagnosed type 2 diabetes and not acutely unwell
- osteopaenia without fracture or complications
- osteoporosis on bone mineral density (BMD) without fracture
- osteoporosis without first-line management
- postmenopausal osteoporosis where:
- treatment has not been initiated and no explanation for not initiating treatment has been provided, or
- treatment has been initiated, but treatment response has not been assessed with repeat bone density and there is no other concern raised
- treatment has not been initiated and no explanation for not initiating treatment has been provided, or
- pre-diabetes
- stable existing type 2 diabetes
- type 2 diabetes managed with dietary measures
- type 2 diabetes well controlled/responding to dietary and medical management with a glycated haemoglobin (HbA1c) less than 8% without associated medical complications, unless identified as high-risk (Aboriginal and Torres Strait Islander)
- unexplained fatigue without endocrine disorder
- children with a thyroid stimulating hormone (TSH) < 10 mU/L and a normal free thyroxine (FT4) and/or positive anti-thyroid peroxidase (anti-TPO) antibodies
- TSH levels should be monitored every 6 to 12 months
- TSH levels should be monitored every 6 to 12 months
- children with exogenous obesity without co-morbidities where lifestyle modification measures have not been trialled
- children with simple vitamin D deficiency
Emergency information
See the individual condition pages for more specific emergency information.
Feedback
We welcome requests for further information or feedback on the CPC and website, please refer to the relevant form below.
Please email the completed form to Health.CPC@sa.gov.au.
Review
The Endocrinology CPC is due for a review in 2028 (adult)
Evidence statement
For a copy of the evidence statement, please email Health.CPC@sa.gov.au.